Amarin Corp Plcuk (AMRN) Inventory (2012 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Inventory of $183.6 million for Q1 2026, up 15.12% YoY from $159.5 million in Q1 2025, and down 6.28% sequentially from $195.9 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Inventory (2012 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Inventory across 15 years of filings, most recently posting $183.6 million for Q1 2026.
- In Q1 2026, Inventory rose 15.12% year-over-year to $183.6 million; the TTM figure through Mar 2026 stood at $183.6 million (up 15.12% YoY), while the FY2025 annual figure was $195.9 million, up 17.98% from the prior year.
- Inventory retreated to $183.6 million in Q1 2026, from $195.9 million in the prior quarter.
- Over the last five years, Inventory for AMRN reached as high as $267.8 million in Q1 2022 and fell as low as $159.5 million in Q1 2025.
- The 5-year median for Inventory is $225.8 million (2023), against an average of $217.4 million.
- The widest YoY moves for Inventory: up 17.98% in 2025, down 37.52% in 2025.
- A 5-year view of Inventory shows it stood at $228.7 million in 2022, then rose by 13.07% to $258.6 million in 2023, then tumbled by 35.79% to $166.0 million in 2024, then gained by 17.98% to $195.9 million in 2025, then slipped by 6.28% to $183.6 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $183.6 million, $195.9 million, and $184.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 14.53 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 14.58 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 5.05 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 6.57 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 6.48 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 6.19 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.91 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 10.67 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | 183.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183.60 Mn |
| Dec 31, 2025 | 195.91 Mn |
| Sep 30, 2025 | 184.70 Mn |
| Jun 30, 2025 | 171.20 Mn |
| Mar 31, 2025 | 159.49 Mn |
| Dec 31, 2024 | 166.05 Mn |
| Sep 30, 2024 | 224.00 Mn |
| Jun 30, 2024 | 239.40 Mn |
| Mar 31, 2024 | 255.28 Mn |
| Dec 31, 2023 | 258.62 Mn |
| Sep 30, 2023 | 254.50 Mn |
| Jun 30, 2023 | 227.02 Mn |
| Mar 31, 2023 | 225.81 Mn |
| Dec 31, 2022 | 228.73 Mn |
| Sep 30, 2022 | 227.60 Mn |
| Jun 30, 2022 | 225.80 Mn |
| Mar 31, 2022 | 267.82 Mn |
| Dec 31, 2021 | 234.68 Mn |
| Sep 30, 2021 | 309.30 Mn |
| Jun 30, 2021 | 272.50 Mn |